ERBB2 and cancer: To compare the mRNA expression of the metastatic HER2-60 and HER2-90 cancer cells, 131 genes were upregulated in HER2-60 metastasized brain tumor cells with more than a 5-fold change and 108 genes were downregulated with less than a 5-fold change.